I mean, IMO the TA is gagged because I think the OS has increased. I could be totally wrong, but I think that is the case. Reading the 8K and reading that Punch was purchased for 135M restricted shares I am comfortable. There are many speculators who won't touch something below the QX. I realize I am lucky to have patient money here, believe me, but big wallets ain't scaring me out before next year. The IMPROVEMENT (not necessarily increase) of the investor base we will find by up listing to OTCQX keeps me from trading this stock and hurting the price or other longs. Looking into the future, Steve will be able to expand the company through revenues instead of increasing the outstanding shares and I plan on sticking around for that stage of the game. I could be totally wrong.. it hurts to watch a stock bring your position down 30-40K in a week but my shares are patient until convinced otherwise. An increase in OS ain't gonna do it in this stage of the game.
I mean, IMO the TA is gagged because I think the OS has
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Revolutionizing Fitness: Strength Training Trends for 2026
Strength Training at the Core of Fitness Trends As the world embraces a new year, the fitness landscape is evolving significantly. The traditional approach of engaging primarily in cardio exercises to reach health goals is being left behind. This year, individuals are increasingly recognizing the myriad benefits of strength training. It has become the foundation upon...
Continue Reading
Armor Health Partners with CCNO to Enhance Care Services
Armor Health Partners with CCNO to Enhance Care Services Armor Health, a leader in integrated correctional healthcare, has successfully taken over health services at the Corrections Center of Northwest Ohio. The transition marks a significant step for both the facility and Armor Health, ensuring that all correctional healthcare needs are met efficiently and...
Continue Reading
Evaluating Twist Bioscience's Upcoming Earnings Report
Preparing for Twist Bioscience's Earnings Announcement Twist Bioscience (NASDAQ: TWST) is set to reveal its quarterly earnings report soon, creating significant anticipation among investors. This article will provide a comprehensive overview in anticipation of this crucial financial announcement. Market Expectations and Earnings Predictions Analysts project that Twist...
Continue Reading
Insights into Snap's Recent Options Activity and Market Position
Insight into Snap's Recent Options Activity Investors are showing a strong bullish sentiment towards Snap (NYSE: SNAP), and this trend is something market watchers should pay attention to. Our thorough review of public option flows reveals significant trading patterns that often signal imminent market changes. We've observed an unparalleled surge in Snap options trading,...
Continue Reading
Canada's Potential Tariffs: A Response to U.S. Trade Actions
Canada's Consideration of Retaliatory Tariffs Discussions are taking place in Canada regarding the imposition of retaliatory tariffs targeting a variety of U.S. goods, with orange juice being prominently mentioned. This potential move arises in response to the threat of a significant 25% tariff on imports from Canada, as suggested by newly elected officials in the United...
Continue Reading